
Opinion|Videos|June 12, 2024
Optimizing PAH Care Delivery for Better Outcomes
Author(s)Marius Hoeper, MD
Following a review of strategies and care delivery models that could help optimize the management of PAH, Marius Hoeper, MD, discusses his recent publication on the long-term impact of sotatercept on morbidity and mortality.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- From a clinical perspective, what strategies or care delivery models could help optimize the management of pulmonary arterial hypertension (PAH) and potentially reduce the overall burden on the health care system while improving patient outcomes?
- Discuss your recent publication on using a population health model to predict the long-term impact of the new PAH therapy sotatercept on morbidity and mortality. How can such modeling tools be leveraged by clinicians to better anticipate and plan for the clinical and economic effects of emerging PAH treatments?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
2
EHA 2026 Had Something for Everyone, From Pediatric Practitioners to “Myeloma Maniacs”
3
Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV
4
How MCOs Should Be Preparing for the OBBBA's Medicaid Cuts: David Brueggeman, MBA
5




